Literature DB >> 15710176

Developmental exposure to terbutaline alters cell signaling in mature rat brain regions and augments the effects of subsequent neonatal exposure to the organophosphorus insecticide chlorpyrifos.

Armando Meyer1, Frederic J Seidler, Justin E Aldridge, Theodore A Slotkin.   

Abstract

Exposure to apparently unrelated neurotoxicants can nevertheless converge on common neurodevelopmental events. We examined the long-term effects of developmental exposure of rats to terbutaline, a beta-adrenoceptor agonist used to arrest preterm labor, and the organophosphorus insecticide chlorpyrifos (CPF) separately and together. Treatments mimicked the appropriate neurodevelopmental stages for human exposures: terbutaline on postnatal days (PN) 2-5 and CPF on PN11-14, with assessments conducted on PN45. Although neither treatment affected growth or viability, each elicited alterations in CNS cell signaling mediated by adenylyl cyclase (AC), a transduction pathway shared by numerous neuronal and hormonal signals. Terbutaline altered signaling in the brainstem and cerebellum, with gender differences particularly notable in the cerebellum (enhanced AC in males, suppressed in females). By itself, CPF exposure elicited deficits in AC signaling in the midbrain, brainstem, and striatum. However, sequential exposure to terbutaline followed by CPF produced larger alterations and involved a wider spectrum of brain regions than were obtained with either agent alone. In the cerebral cortex, adverse effects of the combined treatment intensified between PN45 and PN60, suggesting that exposures alter the long-term program for development of synaptic communication, leading to alterations in AC signaling that emerge even after adolescence. These findings indicate that terbutaline, like CPF, is a developmental neurotoxicant, and reinforce the idea that its use in preterm labor may create a subpopulation that is sensitized to long-term CNS effects of organophosphorus insecticides.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15710176     DOI: 10.1016/j.taap.2004.08.005

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  20 in total

Review 1.  Drugs, biogenic amine targets and the developing brain.

Authors:  Aliya L Frederick; Gregg D Stanwood
Journal:  Dev Neurosci       Date:  2009-04-17       Impact factor: 2.984

2.  Organophosphate pesticide chlorpyrifos impairs STAT1 signaling to induce dopaminergic neurotoxicity: Implications for mitochondria mediated oxidative stress signaling events.

Authors:  Neeraj Singh; Vivek Lawana; Jie Luo; Phang Phong; Ahmed Abdalla; Bharathi Palanisamy; Dharmin Rokad; Souvarish Sarkar; Huajun Jin; Vellareddy Anantharam; Anumantha G Kanthasamy; Arthi Kanthasamy
Journal:  Neurobiol Dis       Date:  2018-05-31       Impact factor: 5.996

3.  Organophosphate exposure during a critical developmental stage reprograms adenylyl cyclase signaling in PC12 cells.

Authors:  Abayomi A Adigun; Ian T Ryde; Frederic J Seidler; Theodore A Slotkin
Journal:  Brain Res       Date:  2010-03-16       Impact factor: 3.252

4.  Developmental neurotoxicity resulting from pharmacotherapy of preterm labor, modeled in vitro: Terbutaline and dexamethasone, separately and together.

Authors:  Theodore A Slotkin; Samantha Skavicus; Frederic J Seidler
Journal:  Toxicology       Date:  2018-03-07       Impact factor: 4.221

5.  Disparate developmental neurotoxicants converge on the cyclic AMP signaling cascade, revealed by transcriptional profiles in vitro and in vivo.

Authors:  Abayomi A Adigun; Frederic J Seidler; Theodore A Slotkin
Journal:  Brain Res       Date:  2009-12-21       Impact factor: 3.252

6.  Developmental neurotoxicity targeting hepatic and cardiac sympathetic innervation: effects of organophosphates are distinct from those of glucocorticoids.

Authors:  Frederic J Seidler; Theodore A Slotkin
Journal:  Brain Res Bull       Date:  2011-03-29       Impact factor: 4.077

Review 7.  Prenatal exposure to drugs: effects on brain development and implications for policy and education.

Authors:  Barbara L Thompson; Pat Levitt; Gregg D Stanwood
Journal:  Nat Rev Neurosci       Date:  2009-03-11       Impact factor: 34.870

8.  Effect of different administration paradigms on cholinesterase inhibition following repeated chlorpyrifos exposure in late preweanling rats.

Authors:  Russell L Carr; Carole A Nail
Journal:  Toxicol Sci       Date:  2008-08-14       Impact factor: 4.849

9.  Unrelated developmental neurotoxicants elicit similar transcriptional profiles for effects on neurotrophic factors and their receptors in an in vitro model.

Authors:  Theodore A Slotkin; Frederic J Seidler; Fabio Fumagalli
Journal:  Neurotoxicol Teratol       Date:  2008-12-13       Impact factor: 3.763

10.  Developmental exposure to terbutaline and chlorpyrifos, separately or sequentially, elicits presynaptic serotonergic hyperactivity in juvenile and adolescent rats.

Authors:  Theodore A Slotkin; Frederic J Seidler
Journal:  Brain Res Bull       Date:  2007-05-11       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.